FIELD: ophthalmology.
SUBSTANCE: invention is intended to assess the activity of the inflammatory process in children with endogenous uveitis. The content of urokinase plasminogen activator is determined in the tear fluid of the diseased eye. When its value is equal to or less than 46.5 pg/ml, the inflammatory process is assessed as inactive, when its value is equal to 46.6–80.6 pg/ml, the inflammatory process is assessed as sluggish, when its value is above 80.7 pg/ml, the inflammatory process is assessed as active.
EFFECT: invention provides the choice of adequate treatment tactics depending on the activity of endogenous uveitis.
1 cl, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR DETERMINING INDICATIONS FOR ACTIVE ANTI-INFLAMMATORY THERAPY BEFORE PERFORMING OPTO-RECONSTRUCTIVE OPERATIONS IN CHILDREN WITH ENDOGENOUS UVEITIS | 2022 |
|
RU2782132C1 |
| METHOD FOR PREDICTION OF DEVELOPING OR PROGRESSING PROLIFERATIVE SYNDROME IN ENDOGENOUS UVEITIS IN CHILDREN | 2015 |
|
RU2584246C1 |
| METHOD FOR PREDICTION OF ORGAN-SPECIFIC SELF-IMMUNISATION IN INFLAMMATORY EYE DISORDERS | 2014 |
|
RU2564929C1 |
| METHOD OF DETERMINING DEGREE OF ACTIVITY OF ENDOGENOUS UVEITES IN CHILDREN BASING ON DATA OF CORNEAL CONFOCAL MICROSCOPY | 2012 |
|
RU2495616C1 |
| METHOD FOR PREDICTION OF CLINICAL COURSES OF UVEITES ASSOCIATED WITH RHEUMATIC DISEASES IN CHILDREN, ACCOMPANYING BASIC THERAPY BY TUMOUR NECROSIS FACTOR ALPHA | 2011 |
|
RU2479848C1 |
| METHOD FOR PREDICTING HIGH RISK OF AUTOIMMUNE INFLAMMATION IN POST-TRAUMATIC UVEITIS IN LONG TERM | 2021 |
|
RU2754292C1 |
| METHOD FOR PREDICTING UNFAVORABLE CLINICAL COURSE OF UVEITIS | 2005 |
|
RU2298188C1 |
| METHOD FOR TREATING ENDOGENOUS AND POSTOPERATIVE UVEITIS | 1996 |
|
RU2107480C1 |
| METHOD FOR COMPLEX TREATMENT OF ENDOGENOUS UVEITIS FOLLOWED BY MACULAR EDEMA | 2016 |
|
RU2635083C1 |
| METHOD OF TREATING EYE DISEASES ACCOMPANIED BY OXIDATIVE STRESS | 2014 |
|
RU2577236C1 |
